Efficacy of Korteksin in acute period of hemispheric ischemic stroke
Belova LA, Mashin VV, Abramova VV, Slastyon EY, Belov DV · 2018 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 30132453
What does this source report?
The authors reported the greatest neurological improvement in one repeated-course group.
- Population and setting
- 122 ischemic-stroke patients in four groups (30, 30, 30 and 32)
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- English
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Randomization and blinding are not established from the abstract.
- Possible participant overlap with the same group’s 2016 report remains unresolved.
- Different treatment schedules do not establish an optimal clinical regimen.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Abstract reviewed
Source access and review scope
Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.
Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Belova LA, Mashin VV, Abramova VV, Slastyon EY, Belov DV. Efficacy of Korteksin in acute period of hemispheric ischemic stroke Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 30132453 2018.
Molekul research summary: https://molekul.io/research/stroke-30132453. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry